Mexico Industry Reports

Mexico is the second-largest pharmaceutical market in Latin America, after Brazil, with retail drug sales of USD 7.3bn in 2019. The country has a growing and ageing population, multiple but underfunded state-run health insurance systems, ...

The transportation sector in Latin America still faces the challenges of most developing countries: inadequate infrastructure; informality; lack of diversity and limited availability of intermodal services. According to the World Economic ...

As of the end of 2019, Latin America and the Caribbean accounted for 19.0% of the world’s crude oil reserves and 4.1% of natural gas reserves, turning the region into a prominent player in the global oil and natural gas industry ...

The Mexican agriculture sector, including crop, livestock and fisheries, plays a key role in the domestic economy. Agriculture GVA accounted for 3.4% of the GDP in 2019, and the sector is among the largest employers in the country, with a ...

In 2019, Mexico consolidated its position as the world’s sixth-largest vehicle manufacturer, with an output of 3.95mn units. During the year, strong foreign demand – especially from the US – was the major driving force for ...

Mexico is the second largest economy in Latin America in terms of nominal GDP, and thereby a key consumer market in the region with a population of over 126mn as of December 2019. Over the period 2014-2019, the retail trade sector performed well, ...

In 2018, the construction sector accounted for 7.6% of Mexico’s GDP, 5% of total FDI inflow and 8.1% of formal employment. Over the 2013-2018 period, the construction sector expanded its GVA at a CAGR of 1.3% in real terms, with the main growth ...

After the passing of the energy reform at the end of 2013, Mexico’s electric power sector experienced positive results. Between 2014 and 2018, power generation grew at a CAGR of 3.1%, supported by a stable 1.7% average annual increase in ...

In the past two decades, Latin America has embraced a universal health strategy, based on the principles of equity, solidarity and collective action. This strategy required steadily growing public expenditure on health in order to guarantee universal ...

Mexico is the second largest pharmaceutical market in Latin America, behind only Brazil, with retail drug sales of USD 10.2bn in 2018. The country also features a growing and ageing population, multiple but underfunded state-run health insurance ...